Evidence map›Paper›PMID 23212921›Full record

ArticleThe Journal of biological chemistry2013

Chemical genetic screen reveals a role for desmosomal adhesion in mammary branching morphogenesis.

Kaitlin J Basham, Collin Kieffer, Dawne N Shelton, Christopher J Leonard, Vasudev R Bhonde, Hariprasad Vankayalapati, Brett Milash, David J Bearss, Ryan E Looper, Bryan E Welm

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Frontiers in immunology · 2023
    Article
  3. Adverse Effects of High Temperature On Mammary Alveolar Development In Vitro.Journal of mammary gland biology and neoplasia · 2022
    Article
  4. Mammary Organoids and 3D Cell Cultures: Old Dogs with New Tricks.Journal of mammary gland biology and neoplasia · 2020
    Review
  5. Article
  6. Article
  7. The Terminal End Bud: the Little Engine that Could.Journal of mammary gland biology and neoplasia · 2017
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kaitlin J BashamDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA.
Collin Kieffer
Dawne N Shelton
Christopher J Leonard
Vasudev R Bhonde
Hariprasad Vankayalapati
Brett Milash
David J Bearss
Ryan E Looper
Bryan E Welm

Funding

DEVELOPMENTAL BIOLOGY TRAINING PROGRAMT32HD007491 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI James Alan Gagnon, Kristen M Kwan · 1995 to 2026
$8.0M
Identification of Novel Cancer Selective Compounds in 3D Tumor Organoid AssaysR01CA140296 · NCI · UNIVERSITY OF UTAH · PI SIGMAN, MATTHEW S · 2009 to 2013
$1.5M
Analysis of the Cellular Origins of Breast CancerR01CA143815 · NCI · UNIVERSITY OF UTAH · PI WELM, BRYAN E. · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA140296NCI NIH HHS R01-CA140296NCI NIH HHS R01 CA143815NCI NIH HHS R01-CA143815NICHD NIH HHS 5T32 HD07491NICHD NIH HHS T32 HD007491
6 · The paper itself

Abstract

During the process of branching morphogenesis, the mammary gland undergoes distinct phases of remodeling to form an elaborate ductal network that ultimately produces and delivers milk to newborn animals. These developmental events rely on tight regulation of critical cellular pathways, many of which are probably disrupted during initiation and progression of breast cancer. Transgenic mouse and in vitro organoid models previously identified growth factor signaling as a key regulator of mammary branching, but the functional downstream targets of these pathways remain unclear. Here, we used purified primary mammary epithelial cells stimulated with fibroblast growth factor-2 (FGF2) to model mammary branching morphogenesis in vitro. We employed a forward chemical genetic approach to identify modulators of this process and describe a potent compound, 1023, that blocks FGF2-induced branching. In primary mammary epithelial cells, we used lentivirus-mediated knockdown of the aryl hydrocarbon receptor (AHR) to demonstrate that 1023 acts through AHR to block branching. Using 1023 as a tool, we identified desmosomal adhesion as a novel target of AHR signaling and show that desmosomes are critical for AHR agonists to block branching. Our findings support a functional role for desmosomes during mammary morphogenesis and also in blocking FGF-induced invasion.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCell AdhesionCells, CulturedCollagenDesmosomesDown-RegulationDrug CombinationsEpithelial CellsFemaleFibroblast Growth Factor 2Fibroblast Growth FactorsGenetic TechniquesLamininMammary Glands, AnimalMammary Neoplasms, AnimalCollagenDrug CombinationsFibroblast Growth Factor 2Fibroblast Growth FactorsLamininmatrigelProteoglycansReceptors, Aryl HydrocarbonRNA, Small Interfering

Identifiers

PMID23212921
PMCPMC3554898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.